|

Carmustine Clinical Trials

4 actively recruiting trials across 3 locations

▼ -1 trial since May 2026

Also known as: BCNU, BCNU,bis-chloronitrosourea, Becenum, Becenun, BiCNU +12 more

Pipeline

Phase 1: 1Phase 2: 3

Top Sponsors

  • Washington University School of Medicine2
  • Leland Metheny1
  • City of Hope Medical Center1

Indications

  • Cancer4
  • Supratentorial Glioblastoma1
  • Supratentorial Gliosarcoma1
  • Recurrent Hodgkin Lymphoma1
  • Glioblastoma Multiforme, Adult1

St Louis, Missouri2 trials

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Washington University School of Medicine

Phase 2
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine/St. Louis Children's Hospital

Phase 1

Duarte, California1 trial

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

City of Hope Medical Center

Phase 2

Cleveland, Ohio1 trial

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

University Hospitals Cleveland Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.